BioSpace News Archive

Protalix BioTherapeutics, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2023 and provide a business update on Thursday, May 4, 2023.

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced the fourth quarter and full-year 2022 financial results and provided a business update.

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced that it will present new preclinical data related to its MYC-HCC and MYC-NSCLC programs at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicago, Illinois, June 2 – 6, 2023.

TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA) today announced that the company will report first quarter 2023 financial results on Thursday, May 11, 2023.

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary delivery system platform to defeat cancer, announced today that it has received written approval from the Dana Farber Cancer Institute Institutional Review Board (IRB) to proceed with its First-in-Human (FIH) Phase 0 clinical trial.

Tiziana Life Sciences Ltd. today announced broad-based findings on the utility of nasal anti-CD3 mAb in the treatment of intracerebral hemorrhage (ICH). The data using a mouse model of collagenase-induced ICH was presented at the Annual American Academy of Neurology conference.

Biomica Ltd. today announced that it has closed a financing round of $20 million.

Indivior PLC (LSE: INDV) today announced its financial results for the period ending March 31, 2023.

Antiva Biosciences today announced the closing of a $53 million Series E equity financing.

Schrödinger, Inc. today published its inaugural Corporate Sustainability Report.